Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription 14.11.2022 4 Ann Surg Oncol 4 BMC Cancer 1 BMC Gastroenterol 1 Br J Cancer 1 Br J Surg 1 Cancer Lett 1 Clin Med Insights Oncol 1 Clin Res Hepatol Gastroenterol 3 Eur J Cancer 2 Gut 2 Int J Cancer 5 Int J Colorectal Dis 1 J Clin Oncol 1 J Surg Oncol 1 Oncogene 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. EL ASMAR A, Delcourt M, Kamden L, Khaled C, et al
   Prognostic Value of Preoperative Serological Biomarkers in Patients Undergoing Curative-Intent Cytoreductive Surgery for Colorectal Cancer Peritoneal Metastases.
   Ann Surg Oncol. 2022 Nov 9. pii: 10.1245/s10434-022-12736.
   PubMed         Abstract available
   
   
2. GRIFFITHS CD, Karanicolas P, Gallinger S, Wei AD, et al
   Health-Related Quality of Life Following Simultaneous Resection for Synchronous Colorectal Cancer Liver Metastases.
   Ann Surg Oncol. 2022 Nov 9. pii: 10.1245/s10434-022-12696.
   PubMed         Abstract available
   
   
3. EL ASMAR A, Liberale G
   ASO Author Reflections: Preoperative Serological Biomarkers as Novel Prognostic Factors in Patients with Peritoneal Metastases of Colorectal Cancer Origin.
   Ann Surg Oncol. 2022 Nov 6. pii: 10.1245/s10434-022-12771.
   PubMed        
   
   
4. SWARTJES H, de Wilt H
   ASO Author Reflections: Real-World Conclusions on Locoregionally Recurrent Colon Cancer.
   Ann Surg Oncol. 2022 Nov 5. pii: 10.1245/s10434-022-12772.
   PubMed        
   
   

   
   BMC Cancer

5. CHENG X, Shen T, Liu P, Fang S, et al
   mir-145-5p is a suppressor of colorectal cancer at early stage, while promotes colorectal cancer metastasis at late stage through regulating AKT signaling evoked EMT-mediated anoikis.
   BMC Cancer. 2022;22:1151.
   PubMed         Abstract available
   
   
6. JAFARI M, Laraqui A, Baba W, Benmokhtar S, et al
   Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa.
   BMC Cancer. 2022;22:1142.
   PubMed         Abstract available
   
   
7. LINCOLN A, Benton S, Piggott C, North BV, et al
   Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, mul
   BMC Cancer. 2022;22:1144.
   PubMed         Abstract available
   
   
8. LIU S, Wang YL, Shi ST, Zeng GD, et al
   The effect of recombinant human epidermal growth factor on radiation dermatitis in rectal and anal cancer patients: a self-controlled study.
   BMC Cancer. 2022;22:1140.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

9. LIU LL, Sun JD, Xiang ZL
   Survival nomograms for colorectal carcinoma patients with lung metastasis and lung-only metastasis, based on the SEER database and a single-center external validation cohort.
   BMC Gastroenterol. 2022;22:446.
   PubMed         Abstract available
   
   

   
   Br J Cancer

10. FAULKNER LG, Howells LM, Pepper C, Shaw JA, et al
    The utility of ctDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Nov 8. pii: 10.1038/s41416-022-02017.
    PubMed         Abstract available
    
    

    
    Br J Surg

11. CONEFREY C, Ochieng C, Hoffman C, Elliott D, et al
    Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic.
    Br J Surg. 2022 Nov 7. pii: 6806207. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer Lett

12. WANG SY, Zhang LJ, Chen GJ, Ni QQ, et al
    COPA A-to-I RNA editing hijacks endoplasmic reticulum stress to promote metastasis in colorectal cancer.
    Cancer Lett. 2022;553:215995.
    PubMed         Abstract available
    
    

    
    Clin Med Insights Oncol

13. FANG Y, Yan C, Zhao Q, Zhao B, et al
    The Association Between Gut Microbiota, Toll-Like Receptors, and Colorectal Cancer.
    Clin Med Insights Oncol. 2022;16:11795549221130549.
    PubMed         Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

14. FLECCHIA C, Zaanan A, Lahlou W, Basile D, et al
    MSI colorectal cancer, all you need to know.
    Clin Res Hepatol Gastroenterol. 2022;46:101983.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

15. LAKBIR S, Lahoz S, Cuatrecasas M, Camps J, et al
    Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer.
    Eur J Cancer. 2022;177:94-102.
    PubMed         Abstract available
    
    
16. PROCACCIO L, Bergamo F, Gatti M, Chiusole B, et al
    The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer.
    Eur J Cancer. 2022;177:112-119.
    PubMed         Abstract available
    
    
17. ARGILES G, Mulet N, Valladares-Ayerbes M, Vieitez JM, et al
    A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
    Eur J Cancer. 2022;177:154-163.
    PubMed         Abstract available
    
    

    
    Gut

18. GIBSON DJ, Sidhu M, Zanati S, Tate DJ, et al
    Oncological outcomes after piecemeal endoscopic mucosal resection of large non-pedunculated colorectal polyps with covert submucosal invasive cancer.
    Gut. 2022;71:2481-2488.
    PubMed         Abstract available
    
    
19. VOSKO S, Shahidi N, Gupta S, van Hattem WA, et al
    'Fish-eye' polypectomy defect: a new sign during endoscopic mucosal resection?
    Gut. 2022;71:2413-2488.
    PubMed        
    
    

    
    Int J Cancer

20. VAN DER KRUIJSSEN DEW, van der Kuil AJS, Vink GR, Punt CJA, et al
    Time-varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: a population-based study and meta-analysis.
    Int J Cancer. 2022 Nov 8. doi: 10.1002/ijc.34347.
    PubMed         Abstract available
    
    
21. RIBE SG, Botteri E, Loberg M, Randel KR, et al
    Impact of time between faecal immunochemical tests in colorectal cancer screening on screening results: A natural experiment.
    Int J Cancer. 2022 Nov 8. doi: 10.1002/ijc.34351.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

22. JIA Z, Wu H, Xu J, Sun G, et al
    Development and validation of a nomogram to predict overall survival in young non-metastatic rectal cancer patients after curative resection: a population-based analysis.
    Int J Colorectal Dis. 2022;37:2365-2374.
    PubMed         Abstract available
    
    
23. CHEN J, Wu Z, Zhang X, Liu Z, et al
    Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer.
    Int J Colorectal Dis. 2022;37:2321-2333.
    PubMed         Abstract available
    
    
24. WENG L, Jin F, Shi J, Qiu Z, et al
    Antibiotics use and risk of colorectal neoplasia: An updated meta-analysis.
    Int J Colorectal Dis. 2022;37:2291-2301.
    PubMed         Abstract available
    
    
25. ZHOU H, Wang S, Cai Z, Qiu E, et al
    Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis.
    Int J Colorectal Dis. 2022 Nov 5. pii: 10.1007/s00384-022-04278.
    PubMed         Abstract available
    
    
26. MORINI A, Annicchiarico A, De Giorgi F, Ferioli E, et al
    Local excision of T1 colorectal cancer: good differentiation, absence of lymphovascular invasion, and limited tumor radial infiltration (
    Int J Colorectal Dis. 2022 Nov 5. pii: 10.1007/s00384-022-04279.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

27. PARSEGHIAN CM, Sun R, Woods M, Napolitano S, et al
    Resistance Mechanisms to Anti-EGFR Therapy in RAS/RAF Wildtype Colorectal Cancer Vary by Regimen and Line of Therapy.
    J Clin Oncol. 2022 Nov 9:101200JCO2201423. doi: 10.1200/JCO.22.01423.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

28. AYLWARD C, Noori J, Tyrrell J, O'sullivan N, et al
    Survival outcomes after synchronous para-aortic lymph node metastasis in colorectal cancer: A systematic review.
    J Surg Oncol. 2022 Nov 9. doi: 10.1002/jso.27139.
    PubMed         Abstract available
    
    

    
    Oncogene

29. CUI K, Gong L, Zhang H, Chen Y, et al
    EXOSC8 promotes colorectal cancer tumorigenesis via regulating ribosome biogenesis-related processes.
    Oncogene. 2022 Nov 8. pii: 10.1038/s41388-022-02530.
    PubMed         Abstract available
    
    

    
    PLoS One

30. ZHANG X, Ma S, Guo Y, Luo Y, et al
    Total neoadjuvant therapy versus standard therapy in locally advanced rectal cancer: A systematic review and meta-analysis of 15 trials.
    PLoS One. 2022;17:e0276599.
    PubMed         Abstract available
    
    
31. ANGER F, Lichthardt S, Haubitz I, Wagner J, et al
    Is there a weekend effect in emergency surgery for colorectal carcinoma? Analysis from the German StuDoQ registry.
    PLoS One. 2022;17:e0277050.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: